Trends in outpatient antibiotic use in Israel during the years 2000-2010: Setting targets for an intervention

Infection

Volumn 41, Issue 2, 2013, Pages 401-407

  Low, M ^a   Nitzan, O ^b,c   Bitterman, H ^a,c   Cohen, C ^a   Hammerman, A ^a   Lieberman, N ^a   Raz, R ^b,c   Balicer, R D ^a,d  

^a CLALIT HEALTH SERVICES   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antibiotics; Consumption; Districts; Outpatients; Trends

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; GLYCOPEPTIDE; MACROLIDE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; UREIDOPENICILLIN;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; DRUG COST; DRUG USE; HEALTH SERVICE; HUMAN; INFANT; ISRAEL; OUTPATIENT CARE; PHARMACY; PRESCHOOL CHILD; REGISTER; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FLUOROQUINOLONES; HUMANS; INFANT; ISRAEL; MIDDLE AGED; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879499182     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0332-8     Document Type: Article

References (20)

1. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011;66:vi3-12.
2. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:1722-30.
3. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2012. Oslo. 2011.
4. Goossens H, Ferech M, Coenen S, Stephens P; European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091-5.
5. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis. 2001;33:S206-13.
6. Kiffer CR, Camargo EC, Shimakura SE, Ribeiro PJ Jr, Bailey TC, Pignatari AC, Monteiro AM. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int J Health Geogr. 2011;10:17.
7. Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother. 2011;66:vi13-23.
8. Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother. 2011;66:vi25-35.
9. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011;66:vi47-56.
10. Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis. 2011;11:99.
11. Hicks LA, Chien YW, Taylor TH Jr, Haber M, Klugman KP; Active Bacterial Core Surveillance (ABCs) Team. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis. 2011;53:631-9.
12. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y; on behalf of the Study Group participants. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2012. (Epub ahead of print).
13. Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39:407-13.
14. Dommergues MA, Hentgen V. Decreased paediatric antibiotic consumption in France between 2000 and 2010. Scand J Infect Dis. 2012;44:495-501.
15. Schneider-Lindner V, Quach C, Hanley JA, Suissa S. Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother. 2011;66:424-33.
16. Franchi C, Sequi M, Bonati M, Nobili A, Pasina L, Bortolotti A, Fortino I, Merlino L, Clavenna A. Differences in outpatient antibiotic prescription in Italy's Lombardy region. Infection. 2011;39:299-308.
17. Pan A, Buttazzi R, Marchi M, Gagliotti C, Resi D, Moro ML; Antibiotic Use and Resistance Surveillance Study Group of Regione Emilia-Romagna. Secular trends in antibiotic consumption in the adult population in Emilia-Romagna, Italy, 2003-2009. Clin Microbiol Infect. 2011;17:1698-703.
18. Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy. 2006;78:77-92.
19. Koller D, Hoffmann F, Maier W, Tholen K, Windt R, Glaeske G. Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany. Infection. 2012. (Epub ahead of print).
20. Nitzan O, Low M, Lavi I, Hammerman A, Klang S, Raz R. Variability in outpatient antimicrobial consumption in Israel. Infection. 2010;38:12-8.